Bio­gen snatch­es ex-Pfiz­er ex­ec as new EVP, cor­po­rate de­vel­op­ment; Io­n­is/Akcea get thumbs up from EMA com­mit­tee on in­ot­ersen

→ Bio­gen has snagged an ex-Pfiz­er ex­ec­u­tive to lead as their new ex­ec­u­tive vice pres­i­dent of cor­po­rate de­vel­op­ment, a new­ly cre­at­ed po­si­tion de­signed to head up busi­ness de­vel­op­ment and strat­e­gy at Bio­gen. Daniel Karp was pre­vi­ous­ly VP of world­wide busi­ness de­vel­op­ment and head of busi­ness dev for R&D at Pfiz­er, a com­pa­ny he’s been with­in vary­ing roles for the past 13 years. There, he led a glob­al team do­ing ear­ly sci­ence trans­ac­tions, along with part­ner­ships and ac­qui­si­tions across Pfiz­er’s re­search port­fo­lio.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER